• (PLX AI) –Ambu says Juan Jose Gonzalez will leave Ambu after three years with the company.
  • • One-off costs associated with the change of CEO of DKK 13m will be accounted for in the interim report for Q3 2021/22
  • • Says announcement does not change the financial guidance for 2021/22 as provided in the interim report for Q2 2021/22 on 5 May 2022
  • • From 2019 Britt Meelby Jensen served as CEO of Swedish Atos Medical until the sale of the company to Coloplast in early 2022
  • • From 2015 to 2019, Britt Meelby Jensen served as CEO of Zealand Pharma

Quelle: PLX AI